Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda
Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. However, CCM remains one of the leading causes of mortality among HIV infected patients especially in sub-Saharan Afr...
Main Authors: | Kitonsa, J, Nsubuga, R, Mayanja, Y, Kiwanuka, J, Nikweri, Y, Onyango, M, Anywaine, Z, Ggayi, A-B, Kibengo, FM, Kaleebu, P, Day, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2020
|
Similar Items
-
Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda.
by: Jonathan Kitonsa, et al.
Published: (2019-01-01) -
Adjunctive dexamethasone in HIV-associated cryptococcal meningitis
by: Beardsley, J, et al.
Published: (2016) -
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis
by: Kitonsa, J, et al.
Published: (2021) -
Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.
by: Jonathan Kitonsa, et al.
Published: (2021-03-01) -
The authors reply: Dexamethasone in Cryptococcal Meningitis
by: Beardsley, J, et al.
Published: (2016)